Your Journey
Cancer Types
Advocacy Partner News
Conferences
INFORMATION BY CANCER TYPE
Brain
Feature Video
Watch a video about Chad, a patient using Optune.
Learn how Chad manages his treatment while enjoying his favorite activities.
Learn how Chad manages his treatment while enjoying his favorite activities.
Those of us who have suffered often fear what can go wrong with them. But the more we know our bodies, the more we can love them and ourselves.
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).
Both oncologists and primary care physicians do not provide adequate care to fully address cancer survivorship needs. Learn about why and solutions for people in their cancer journey.
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, offers advice for patients who have recently been diagnosed with glioblastoma (GBM).
In early 2015, Zika outbreaks caused widespread panic in many parts of North and South America. However, now researchers are exploring the possibility of putting the virus to good use: fighting glioblastoma multiforme (GBM), the most deadly type of brain cancer.
The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.
Every six months, I get an MRI to check for recurrence or growth of my brain tumor. This is one of those times. To prepare for tomorrow, I try to remember not to forgo today.
A phase 2 trial – which is still enrolling patients – is investigating multiple targeted agents for the treatment of patients with glioblastoma (GBM).
Moving with a health problem comes with the logistical challenge of finding resources in a new place which is a task conquered through patience, kindness and a lot of organization.
The designation recognizes that the vaccine, an immunotherapy called SurVaxM, would treat a rare disease, defined as one that affects a patient population of less than 200,000 Americans. However, because it acts on a protein that appears in 80 percent of cancers generally, SurVaxM may have wider applications.
Special Feature
Talk about this article with other patients, caregivers, and advocates in the Brain CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Brain Tumors Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of adult brain tumors.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of various childhood brain tumors.
Childhood Brain Stem Glioma Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of childhood brain stem glioma.
